BioSpace News Archive

BioForest

Magnolia Medical Expands Steripath® Micro Initial Specimen Diversion Device® (ISDD®) Product Family with New FDA 510(k) Clearance

Magnolia Medical Technologies, Inc., announced today U.S. Food and Drug Administration (FDA) 510(k) clearance of 19 new Steripath® Micro configurations within the company’s ISDD® product portfolio.

April 11, 2023

·

6 min read

BioCapital

Breaking Research That Could Improve Cardiac Care for Children Published in AACC’s The Journal of Applied Laboratory Medicine

A first-of-its-kind study has established pediatric reference intervals for two common tests for cardiovascular disease. Published in AACC’s The Journal of Applied Laboratory Medicine, these findings are crucial to advancing diagnosis and treatment of heart conditions in children.

April 11, 2023

·

3 min read

Business

Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business Update

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, today announced financial results for the year ended December 31, 2022 and recent corporate highlights.

April 11, 2023

·

9 min read

Business

Kronos Bio Announces Changes to Board of Directors

Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer, announced the appointment of Katherine Vega Stultz to its Board of Directors, replacing Otello Stampacchia, Ph.D., who stepped down as of March 31, 2023.

April 11, 2023

·

2 min read

InflaRx Announces Public Offering of Ordinary Shares - April 11, 2023

InflaRx N.V., a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced that it has commenced an underwritten public offering of ordinary shares of the Company.

April 11, 2023

·

6 min read

Pharm Country

Rocket Pharmaceuticals to Participate in Upcoming April 2023 Investor Conferences

Rocket Pharmaceuticals, Inc. announced that Company management will participate in the 22nd Annual Needham Virtual Healthcare Conference and Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit.

April 11, 2023

·

5 min read

Pharm Country

Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate UCART22

Cellectis today announced that the first patient in Europe has been dosed in France with its in-house manufactured product candidate UCART22 and completed the 28-day Dose Limiting Toxicity period.

April 11, 2023

·

5 min read

Policy

PLx Pharma Inc. Receives Nasdaq Delisting Notice - April 11, 2023

PLx Pharma Inc., is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs.

April 11, 2023

·

4 min read

Business

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 9, 2023

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2023 results on Tuesday, May 9, 2023.

April 11, 2023

·

1 min read

Pharm Country

Intra-Cellular Therapies to Present at the 22nd Annual Needham Virtual Healthcare Conference

Intra-Cellular Therapies, Inc. announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 22nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, 2023 at 11:45 a.m. ET.

April 11, 2023

·

1 min read